HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

3- (5- hydroxy- 2,2- dimethyl- chroman- 6- yl)- N- (2- (3- (5- hydroxy- 2,2- dimethyl- chroman- 6- yl)- propionylamino)- ethyl)- propionamide

structure in first source

Networked: 0 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 207
- 1-Ring Heterocyclic Compounds
  - Pyrans: 131
    - Benzopyrans: 198
      - Coumarins: 856
        3-(5-hydroxy-2,2-dimethyl-chroman-6-yl)-N-(2-(3-(5-hydroxy-2,2-dimethyl-chroman-6-yl)-propionylamino)-ethyl)-propionamide
      - Chromans: 3
        3-(5-hydroxy-2,2-dimethyl-chroman-6-yl)-N-(2-(3-(5-hydroxy-2,2-dimethyl-chroman-6-yl)-propionylamino)-ethyl)-propionamide
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 198
      - Coumarins: 856
        3-(5-hydroxy-2,2-dimethyl-chroman-6-yl)-N-(2-(3-(5-hydroxy-2,2-dimethyl-chroman-6-yl)-propionylamino)-ethyl)-propionamide
      - Chromans: 3
        3-(5-hydroxy-2,2-dimethyl-chroman-6-yl)-N-(2-(3-(5-hydroxy-2,2-dimethyl-chroman-6-yl)-propionylamino)-ethyl)-propionamide